Neurology Today in 5
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the latest issue.
Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Total monthly reach
Based on the show's feed history.
Built from
By chart position
- 🇩🇰DK · Medicine#25849 to 7.6K
- 🇲🇽Mexico · Medicine#129298 to 2.7K
- 🇸🇦SA · Medicine#76184 to 1.7K
- 🇹🇭TH · Medicine#71168 to 1.5K
- 🇵🇹Portugal · Medicine#9990 to 807
- Per-Episode Audience
Est. listeners per new episode within ~30 days
1.7K to 15K🎙 Weekly cadence·100 episodes·Last published 1w ago - Monthly Reach
Unique listeners across all episodes (30 days)
3.3K to 30K🇺🇸71%🇩🇰15%🇲🇽5%+4 more - Active Followers
Loyal subscribers who consistently listen
1.8K to 17K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
| Date | Episode | Description | Length | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 10/15/26 |  Lamotrigine in Pregnancy, Professional Mentorship, CADASIL Misdiagnosis | In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about the use of lamotrigine during pregnancy, the value of professional mentorship, and the misdiagnosis of CADASIL as multiple sclerosis. | 4m 30s | ||||||
| 10/1/26 | Wearable Devices, Thrombectomy Debate, Muscular Dystrophy Therapy | In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about the pros and cons of wearable devices, new data for thrombectomy use in medium-vessel occlusion strokes, and a new treatment for limb-girdle muscular dystrophy type 2I/R9. | 4m 28s | ||||||
| 9/17/26 | Oral PCSK9 Inhibitor, Role of Neurology Department Chairs, Anti-IgLON5 Disease | In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about the first oral PCSK9 inhibitor, the transforming role of the neurology department chair, and anti-IgLON5 disease. | 5m 02s | ||||||
| 9/3/26 | New Migraine Prevention Guidelines, Plasmapheresis for MOGAD Attacks, Benefits of Sabbaticals | In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles about new migraine prevention guidelines, the use of plasmapheresis for acute MOGAD attacks, and how sabbaticals can help neurologists avoid burnout. | 4m 56s | ||||||
| 8/20/26 | 'One Big Beautiful Bill Act' Impact, Artificial Intelligence and Workload, GBA1 Mutations in Parkinson's Disease | In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles about the impact of the "One Big Beautiful Bill Act" on neurology practice and research, how artificial intelligence is transforming the neurologist's workload, and the relationship between GBA1 mutations and Parkinson's disease. | 4m 38s | ||||||
| 8/6/26 | American Board of Psychiatry and Neurology Academic Pathway, EpiWatch App, Multiplexed MR Scanning | In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles about a pilot American Board of Psychiatry and Neurology Academic Pathway, a study of the EpiWatch app, and a new approach to magnetic resonance scanning. | 5m 05s | ||||||
| 7/16/26 | Cognitive Decline Biomarker, Tirofiban's Impact on Stroke, Peer Reviewers' Use of Artificial Intelligence | In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles about a blood test that could predict cognitive decline before pathological signs, the use of tirofiban after tenecteplase for stroke, and the role of artificial intelligence in peer review. | 4m 58s | ||||||
| 7/2/26 | OCEANIC-STROKE Study Results, High-Dose Flu Vaccine and Alzheimer's Risk, Role of Osteopathic Medicine in Neurology | In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles about asundexian reducing recurrent ischemic stroke, the link between the high-dose flu vaccine and Alzheimer's dementia incidence, and the evolving role of osteopathic medicine in neurology. | 4m 54s | ||||||
| 6/18/26 | Wait Times for New Neurology Visits, Post-Traumatic Headache Severity in Children, New Drug for Alzheimer's Agitation | In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about appointment wait times for commercially insured patients, post-traumatic headache severity in children with a family history of migraine, and the FDA approval of a drug for Alzheimer's agitation. | 4m 54s | ||||||
| 6/4/26 | Meat Intake and Cognitive Decline, Geographic Distribution of Research Funding, Artificial Intelligence's Role in Neurology | In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about a link between higher meat and slower cognitive decline in APOE34/44 carriers, the geographic distribution of research funding, and how artificial intelligence is reshaping neurology. | 4m 54s | ||||||
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 5/21/26 | New Dopamine Agonist for Parkinson's, Artificial Intelligence in Medical Journals, Coffee and Dementia Risk | In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about a new selective dopamine agonist for people with Parkinson's disease, the use of artificial intelligence in preparing journal manuscripts, and caffeinated coffee's role in reducing dementia risk. | 4m 32s | ||||||
| 5/7/26 | Neurology Match Day Growth, Diabetes and Dementia Risk, Public Health Discourse | In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about the increase in neurology residency matches this year, the risk of dementia in people with Type 1 diabetes, and the role of neurologists in the public health conversation. | 4m 57s | ||||||
| 4/16/26 | Academic Jobs for Fellowship Graduates, Complex Neuromuscular Treatments, New Stroke Guideline | In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about the academic job market for fellowship graduates, the challenges of today's complex neuromuscular therapies, and the changes made in a new stroke guideline. | 5m 12s | ||||||
| 4/2/26 | Acetaminophen Use During Pregnancy, Air Pollution and Motor Neuron Disease, Fremanezumab for Pediatric Migraine | In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about acetaminophen use during pregnancy, the link between air pollution and motor neuron disease risk, and the use of fremanezumab for pediatric migraine. | 5m 06s | ||||||
| 3/19/26 | ACGME neurocritical care accreditation, Jamaica hurricane aftermath, rituximab for multiple sclerosis | In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about ACGME neurocritical care accreditation, how neurologists in Jamaica are recovering from hurricane damage, and the use of rituximab maintenance dosing in multiple sclerosis. | 4m 46s | ||||||
| 3/5/26 | West Nile Neuroinvasive Disease, NINDS Director's Departure, Advanced Practice Provider Educational Funding | In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about West Nile neuroinvasive disease, what's next after NINDS director Dr. Walter Koroshetz's departure, and changes to funding for advanced practice providers' education. | 5m 00s | ||||||
| 2/19/26 | EMG Expertise, GLP-1s and Epilepsy, Astrocytoma Combination Therapy | In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about EMG expertise, GLP-1s and epilepsy risk reduction, and combination therapy for recurrent IDH-mutant astrocytoma. | 4m 38s | ||||||
| 2/5/26 | Lasmiditan Discontinuation, DAAN Designation, Alteplase for Eye Stroke | In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about the discontinuation of lasmiditan, the new DAAN designation, and the use of alteplase after eye stroke. | 4m 44s | ||||||
| 1/15/26 | Genetic Counselors, Wrist-Worn Stimulation Device for Essential Tremor, CREST-2 Study Results | In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about the growing role of genetic counselors in neurology, a wrist-worn stimulation device for essential tremor, and results from the CREST-2 study of asymptomatic carotid disease. | 5m 09s | ||||||
| 1/2/26 | Shunt Benefit in iNPH, Downstream Revenue, Anticoagulant Monotherapy | In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about the benefit of shunts in idiopathic normal-pressure hydrocephalus, how neurologists drive downstream revenue, and anticoagulant monotherapy after stroke. | 4m 59s | ||||||
| 12/18/25 | P-tau217 Alzheimer's Blood Test, Tirofiban With Thrombolysis, Artificial Intelligence in Diagnostic Coding | In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about a p-tau217 blood test for Alzheimer's disease, the benefits of tirofiban with thrombolysis, and an AI tool that excels in diagnostic coding. | 4m 46s | ||||||
| 12/4/25 | Medical school acceptance, hemorrhagic stroke surgery, brain tumors after TBI | In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about medical school acceptance rates after the ending of affirmative action, minimally invasive surgery for hemorrhagic stroke, and the increased risk of brain tumors after traumatic brain injury. | 4m 37s | ||||||
| 11/20/25 | Artificial sweeteners cognition concerns, drug company payments and prescribing decisions, graphene technology | In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about artificial sweeteners' impact on cognitive health, how drug company payments influence prescribing decisions, and the use of graphene technology to accelerate maturation of neurons. | 4m 46s | ||||||
| 11/6/25 | 50 years of monoclonal antibodies, pregabalin and heart failure, combined therapy for primary progressive aphasia | In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about how monoclonal antibodies revolutionized neurologic treatment, why pregabalin link to increased heart failure, and a combined therapy that slows progression in primary progressive aphasia. | 4m 24s | ||||||
| 10/16/25 | Novel PET radiotracer, GLP-1s and dementia risk, green space benefits | In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about a PET radiotracer that shows intranasally delivered insulin enters the brain, GLP-1s and dementia risk in people with Type 2 diabetes, and how exposure to green space may reduce the risk of neurodevelopmental delays in children. | 4m 49s | ||||||
Showing 25 of 100
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Chart history for Neurology Today in 5
Peaked at #25 in Denmark, currently #25 in Denmark.
| Market | Genre | Peak | Current | Trend |
|---|---|---|---|---|
| Denmark | — | #25 | #25 | — |
| TH | — | #71 | #71 | — |
| SA | — | #76 | #76 | — |
| PT | — | #99 | #99 | — |
| Mexico | — | #129 | #129 | — |
| IL | — | #191 | #191 | — |
| ID | — | #192 | #192 | — |
| South Africa | — | #198 | #198 | — |
Chart Positions
8 placements across 8 markets.
Chart Positions
8 placements across 8 markets.